Understanding the Role of Sodium Lauryl Sulfate on the Biorelevant Solubility of a Combination of Poorly Water-Soluble Drugs Using High Throughput Experimentation and Mechanistic Absorption Modeling
DOI:
https://doi.org/10.18433/jpps30347Abstract
This study investigates the influence of surfactant sodium lauryl sulfate (SLS) on the solubility of poorly-water soluble drug substances, model Compound X and Compound Y, used in a fixed dose combination oral solid dosage form. To determine the impact of SLS concentration on the solubility of compounds X and Y, we experimentally determined the critical micelle concentration (CMC) of SLS in water, simulated gastric fluid (SGF), and fed state simulated intestinal fluid (FeSSIF) in the presence of Compound X and Compound Y using UV/Visible spectrophotometry at 25°C. The aggregation of SLS was characterized by calculating the standard Gibbs free energy of micellization in all the media investigated. To enhance the understanding of SLS aggregation, high throughput experiments and in-vivo mechanistic modelling were used to determine the effect of increasing levels of SLS on the solubility of compounds X and Y as both single agent and combination products to be formulated into a suitable oral solid dosage form. Micellar formation of SLS is a spontaneous process as shown by the negative values of the standard free energy of micellization. The CMC of SLS in the various media investigated in the presence of compounds X and Y decreases in the following order: water> FeSSIF> SGF. However, the aggregation of SLS in the various media is overall more spontaneous in the following order: SGF>FeSSIF>water. Using high throughput experimentation and in-vivo mechanistic modelling, it was determined that a combination oral solid product of compounds X and Y will have optimum solubility and in-vivo absorption if 2 mg of SLS was used in the oral solid dosage form. The results obtained from this study will help broaden the understanding of the micellization process involving SLS and poorly-water soluble drugs used in combination oral solid dosage forms.
Downloads
References
Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability. Pharmaceutical Research. 1995;12(3):413-20.
Yu LX, Amidon GL, Polli JE, Zhao H, Mehta MU, Conner DP, et al. Biopharmaceutics classification system: the scientific basis for biowaiver extensions. Pharm Res. 2002;19(7):921-5.
Wu CY, Benet LZ. Predicting drug disposition via application of BCS: Transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharmaceutical Research. 2005;22(1):11-23.
Prentis RA, Lis Y, Walker SR. Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). British Journal of Clinical Pharmacology. 1988;25(3):387-96.
Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins: basic science and product development. Journal of Pharmacy and Pharmacology. 2010;62(11):1607-21.
Singh A, Worku ZA, Van den Mooter G. Oral formulation strategies to improve solubility of poorly water-soluble drugs. Expert Opinion on Drug Delivery. 2011;8(10):1361-78.
Liversidge GG, Cundy KC. Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs. International Journal of Pharmaceutics. 1995;125(1):91-7.
Khadka P, Ro J, Kim H, Kim I, Kim JT, Kim H, et al. Pharmaceutical particle technologies: An approach to improve drug solubility, dissolution and bioavailability. Asian Journal of Pharmaceutical Sciences. 2014;9(6):304-16.
Ware EC, Lu DR. An Automated Approach to Salt Selection for New Unique Trazodone Salts. Pharmaceutical Research. 2004;21(1):177-84.
Schultheiss N, Henck J-O. Chapter 6 Role of Co-crystals in the Pharmaceutical Development Continuum. Pharmaceutical Salts and Co-crystals: The Royal Society of Chemistry; 2012. p. 110-27.
Thompson DO. Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals. Critical reviews in therapeutic drug carrier systems. 1997;14(1):1-104.
Fleisher D, Bong R, Stewart BH. Improved oral drug delivery: solubility limitations overcome by the use of prodrugs. Advanced Drug Delivery Reviews. 1996;19(2):115-30.
Pouton CW. Lipid formulations for oral administration of drugs: non-emulsifying, self-emulsifying and 'self-microemulsifying' drug delivery systems. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2000;11 Suppl 2:S93-8.
Serajuddin AT. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs. Journal of pharmaceutical sciences. 1999;88(10):1058-66.
Janssens S, Van den Mooter G. Review: physical chemistry of solid dispersions. The Journal of pharmacy and pharmacology. 2009;61(12):1571-86.
Ellenberger DJ, Miller DA, Williams RO, 3rd. Expanding the Application and Formulation Space of Amorphous Solid Dispersions with KinetiSol(R): a Review. AAPS PharmSciTech. 2018;19(5):1933-56.
Hanada M, Jermain SV, Lu X, Su Y, Williams RO, 3rd. Predicting physical stability of ternary amorphous solid dispersions using specific mechanical energy in a hot melt extrusion process. Int J Pharm. 2018;548(1):571-85.
Hanada M, Jermain SV, Williams RO, 3rd. Enhanced Dissolution of a Porous Carrier-Containing Ternary Amorphous Solid Dispersion System Prepared by a Hot Melt Method. Journal of pharmaceutical sciences. 2018;107(1):362-71.
Gursoy RN, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2004;58(3):173-82.
Pouton CW. Formulation of poorly water-soluble drugs for oral administration: Physicochemical and physiological issues and the lipid formulation classification system. European Journal of Pharmaceutical Sciences. 2006;29(3):278-87.
Padrela L, Rodrigues MA, Velaga SP, Matos HA, de Azevedo EG. Formation of indomethacin-saccharin cocrystals using supercritical fluid technology. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2009;38(1):9-17.
Dahan A, Hoffman A. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs. Journal of controlled release : official journal of the Controlled Release Society. 2008;129(1):1-10.
Nazzal S, Nutan M, Palamakula A, Shah R, Zaghloul AA, Khan MA. Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients. Int J Pharm. 2002;240(1-2):103-14.
Hsieh AG, Punckt C, Korkut S, Aksay IA. Adsorption of Sodium Dodecyl Sulfate on Functionalized Graphene Measured by Conductometric Titration. The Journal of Physical Chemistry B. 2013;117(26):7950-8.
van Breemen RB, Li Y. Caco-2 cell permeability assays to measure drug absorption. Expert opinion on drug metabolism & toxicology. 2005;1(2):175-85.
Sugano K, Okazaki A, Sugimoto S, Tavornvipas S, Omura A, Mano T. Solubility and dissolution profile assessment in drug discovery. Drug metabolism and pharmacokinetics. 2007;22(4):225-54.
Sugano K. Introduction to computational oral absorption simulation. Expert opinion on drug metabolism & toxicology. 2009;5(3):259-93.
Takano R, Sugano K, Higashida A, Hayashi Y, Machida M, Aso Y, et al. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test. Pharm Res. 2006;23(6):1144-56.
Sugano K. Theoretical comparison of hydrodynamic diffusion layer models used for dissolution simulation in drug discovery and development. Int J Pharm. 2008;363(1-2):73-7.
Bhardwaj V, Sharma P, Chauhan MS, Chauhan S. Micellization, interaction and thermodynamic study of butylated hydroxyanisole (synthetic antioxidant) and sodium dodecyl sulfate in aqueous-ethanol solution at 25, 30 and 35°C. Journal of Saudi Chemical Society. 2016;20:S109-S14.
Pal A, Chaudhary S. Ionic liquids effect on critical micelle concentration of SDS: Conductivity, fluorescence and NMR studies. Fluid Phase Equilibria. 2014;372:100-4.
Alhmoud H, Ibrahim NE, El-Hallous E. Surfactants Solubility, Concentration and the other Formulations Effects on the Drug Release Rate From a Controlled-Release Matrix2014. 364 p.
Zheng W, Jain A, Papoutsakis D, Dannenfelser R-M, Panicucci R, Garad S. Selection of oral bioavailability enhancing formulations during drug discovery. Drug Development and Industrial Pharmacy. 2012;38(2):235-47.
Logan C. Use of Animals for the Determination of Absorption and Bioavailability. In: Mannhold, editor. Drug Bioavailability. Methods and Principles in Medicinal Chemistry2004. p. 132-54.
Jones HM, Parrott N, Ohlenbusch G, Lavé T. Predicting Pharmacokinetic Food Effects Using Biorelevant Solubility Media and Physiologically Based Modelling. Clinical Pharmacokinetics. 2006;45(12):1213-26.
Promzeleva M, Chislov M, Volkova T, Proshin A, Kumeev R, Terekhova I. Effects of Biorelevant Media Components on Dissolution Behaviour of 1,2,4-Thiadiazole Derivative Designed for Alzheimerʼs Disease Prevention. Chemistry & Biodiversity. 2018;15(2):1-9.
Dressman JB, Vertzoni M, Goumas K, Reppas C. Estimating drug solubility in the gastrointestinal tract. Advanced Drug Delivery Reviews. 2007;59(7):591-602.
Willmann S, Schmitt W, Keldenich J, Lippert J, Dressman JB. A physiological model for the estimation of the fraction dose absorbed in humans. Journal of medicinal chemistry. 2004;47(16):4022-31.
Dokoumetzidis A, Valsami G, Macheras P. Modelling and simulation in drug absorption processes. Xenobiotica; the fate of foreign compounds in biological systems. 2007;37(10-11):1052-65.
Fagerberg JH, Tsinman O, Sun N, Tsinman K, Avdeef A, Bergström CAS. Dissolution Rate and Apparent Solubility of Poorly Soluble Drugs in Biorelevant Dissolution Media. Molecular Pharmaceutics. 2010;7(5):1419-30.
Downloads
Published
How to Cite
Issue
Section
License
This is an open access journal with free of charge non-commercial download. At the time of submission, authors will be asked to transfer the copyright to the accepted article to the Journal of Pharmacy and Pharmaceutical Sciences. The author may purchase the copyright for $500 upon which he/she will have the exclusive copyright to the article. Nevertheless, acceptance of a manuscript for publication in the Journal is with the authors' approval of the terms and conditions of the Creative Commons copyright license Creative Common license (Attribution-ShareAlike) License for non-commercial uses.
CLOCKSS system has permission to collect, preserve, and serve this Archival Unit.
